Lloyds Banking Group Q4 results show strong trends with net interest margin growth and resilient assets. See why we believe ...

Eli Lilly’s (LLY) new weight loss pill is still in clinical trials and has not yet been approved by regulators. But that hasn ...

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and ...

We recently compiled a list of the 12 Best Long-Term Stocks to Buy According to Ken Fisher. In this article, we are going to ...

Pharmaceutical company Eli Lilly (LLY) has been raking it in lately thanks to its two flagship products: Mounjaro and Zepbound. These two have ...

Leverage these to understand future stock performance and identify high performing investment ideas. You can also filter these to get relevant data aligned with your investing style and specific ...

Biogen Inc. (NASDAQ: BIIB) has steadily declined since peaking at $468.55 in 2021, as shares are trading down 70.64% from ...

But these nitpickers miss the big picture. Splits matter - because these stocks outperform after the announcement, by a lot. Average returns one year later are 25% vs. 12% for the S&P 500 SPX as a ...

Discover key insights on IWLG, an actively managed ETF with tech focus. Explore its performance vs. SCHG and Russell 1000 ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.